INNOGEN-B (02591) announced that on March 17, 2026, the company submitted an application to the China Securities Regulatory Commission for the proposed conversion of all its domestic unlisted shares into H-shares. Upon obtaining all relevant approvals and/or completing required filings—including the filing notice from the CSRC and approval from the Hong Kong Stock Exchange—and complying with all applicable laws, rules, and regulations, these domestic non-listed shares will be converted into H-shares. The company will then apply for approval to list and trade these H-shares on the Main Board of the Hong Kong Stock Exchange. According to the company's articles of association, no further shareholder meeting approval is required for the conversion and listing.